baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Moleculin Biotech Inc/ US60855D3098 /

2024-04-19 10:00:00 PM	Chg. +0.1265	Volume	Bid11:35:31 PM	Ask11:35:31 PM	High	Low
4.6500USD	+2.80%	10,562 Turnover: 31,845.0109	4.3200Bid Size: 400	4.8400Ask Size: 100	4.6600	4.4001

GlobeNewswire 2021-03-10 Roth Capital Partners 33rd Annual Conference to be held Virtually March 15-17, 2021

GlobeNewswire 2020-06-29 Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

GlobeNewswire 2020-06-23 Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020

GlobeNewswire 2020-05-27 Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.

GlobeNewswire 2020-05-18 Nasdaq Halts Moleculin Biotech Inc.

GlobeNewswire 2020-04-29 WPD Pharmaceutical’s Annamycin Drug Approved for Accelerated European Clinical Trial

GlobeNewswire 2020-04-21 WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQ...

GlobeNewswire 2020-04-16 WPD Pharmaceuticals’ License Partner, Moleculin Biotech to Host Conference Call to Discuss COVID-19 ...

GlobeNewswire 2020-04-13 WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020

GlobeNewswire 2020-04-09 WPD Pharmaceuticals Clarifies News on Licensed Drug Candidate

GlobeNewswire 2020-04-09 WPD Pharmaceuticals Reports Active Compound in Licensed Drug Candidate Reduces Coronavirus Replicati...

GlobeNewswire 2020-04-08 WPD Pharmaceuticals Provides Corporate Update

GlobeNewswire 2020-04-01 WPD Pharmaceuticals Welcome Dr. Waldemar Debinski to its Scientific Advisory Board

GlobeNewswire 2020-03-30 Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

GlobeNewswire 2020-03-24 Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

GlobeNewswire 2020-03-24 Moleculin to Present at the Life Sciences Investor Forum

GlobeNewswire 2020-03-24 WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other ...

GlobeNewswire 2020-03-19 WPD PHARMACEUTICALS’ WP1122 DRUG TO BE TESTED ON A RANGE OF VIRUSES INCLUDING CORONAVIRUS

GlobeNewswire 2020-03-16 WPD PHARMACEUTICALS ANNOUNCES BRAIN CANCER PATIENT FROM BERUBICIN PHASE 1 TRIAL REMAINS CANCER FREE

GlobeNewswire 2020-03-13 WPD PHARMACEUTICALS ANNOUNCES BRAIN CANCER PATIENT FROM BERUBICIN PHASE 1 TRIAL REMAINS CANCER FREE

GlobeNewswire 2020-03-11 WPD PHARMACEUTICALS RECEIVED $800,000 REIMBURSEMENT FROM $7.4 MILLION GOVERNMENT GRANT FOR DEVELOPME...

GlobeNewswire 2020-03-04 WPD Pharmaceuticals’ Brain Cancer Drug Received Positive FDA Pre-IND Guidance

GlobeNewswire 2020-02-27 WPD Pharmaceuticals’ Annamycin Received Positive Interim Results From Phase 1/2 Clinical Studies in ...

GlobeNewswire 2020-02-24 WPD Pharmaceuticals Granted Key Patent Exclusively Licensed From Wake Forest University

GlobeNewswire 2020-02-20 WPD Pharmaceuticals' STAT3 Inhibitor Received FDA Approval of IND Status in Pediatric Brain Cancer T...

Moleculin Biotech Inc/ US60855D3098 /

If you wish to receive reply to your feedback, please provide your email address.